The potential role of non-coding RNAs in the response of the transcriptome to the action of the peptide drug Semax in cerebral ischemia in rats
https://doi.org/10.25557/2073-7998.2026.03.53-58
Abstract
The use of neuroprotective drugs is a key approach in the treatment of ischemic stroke. Natural peptides, including adrenocorticotropic hormone (ACTH), can serve as the basis for such drugs. The synthetic peptide ACTH(4-7)PGP (Semax) has pronounced nootropic and neuroprotective effects. We previously demonstrated that Semax compensates for changes in gene expression in the rat brain that occur during cerebral ischemia; however, the nature of Semax’s compensatory effect at the transcriptome level remains unclear. We also previously demonstrated that the level of noncoding circular RNAs (circRNAs) significantly changes in the rat brain under ischemic conditions. These circRNAs can act as molecules regulating gene expression by controlling microRNA activity. Under ischemia-reperfusion model conditions in the ipsilateral frontal cortex of rats, containing the penumbra region, we identified genes whose expression is altered by Semax and simultaneously under the control of circRNAs at 24 hours after the onset of middle cerebral artery occlusion. Thus, a possible role of non-coding RNAs in the mechanisms of Semax’s effect on the brain cell transcriptome under ischemic conditions was demonstrated.
Keywords
About the Authors
I. B. FilippenkovRussian Federation
Ivan B. Filippenkov
1 Kurchatov sq., Moscow, 123182; 1 Moskvorechye st., Moscow, 115522
I. V. Mozgovoy
Russian Federation
1 Kurchatov sq., Moscow, 123182
O. Y. Sudarkina
Russian Federation
1 Kurchatov sq., Moscow, 123182
L. V. Dergunova
Russian Federation
1 Kurchatov sq., Moscow, 123182
L. A. Andreeva
Russian Federation
1 Kurchatov sq., Moscow, 123182
N. F. Myasoedov
Russian Federation
1 Kurchatov sq., Moscow, 123182
S. A. Limborska
Russian Federation
1 Kurchatov sq., Moscow, 123182
References
1. Scherrer K. Primary Transcripts: From the Discovery of RNA Processing to Current Concepts of Gene Expression Review. Exp Cell Res. 2018;373:1-33.
2. Filippenkov I.B., Kalinichenko E.O., Limborska S.A., Dergunova L.V. Circular RNAs—One of the Enigmas of the Brain. Neurogenetics. 2017;18:1-6.
3. Dergunova L.V., Vinogradina M.A., Filippenkov I.B. et al. Circular RNAs Variously Participate in Coronary Atherogenesis. Curr. Issues Mol. Biol. 2023;45:6682-6700.
4. Zhou M., Li S., Huang C. Physiological and Pathological Functions of Circular RNAs in the Nervous System. Neural Regen Res. 2024;19:342-349.
5. Dube U., Del-Aguila J.L., Li Z. et al. An Atlas of Cortical Circular RNA Expression in Alzheimer Disease Brains Demonstrates Clinical and Pathological Associations. Nat Neurosci. 2019;22:1903-1912.
6. Zhang Y., Zhang X.O., Chen T. et al. Circular Intronic Long Noncoding RNAs. Mol Cell 2013;51:792-806.
7. Gusev E.I., Martynov M.Yu., Kostenko E.V. et al. Effektivnost’ semaksa pri lechenii bol’nykh na raznykh stadiyakh ishemicheskogo insul’ta [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]. Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova [S.S. Korsakov Journal of Neurology and Psychiatry]. 2018;118(3-2):61-68. (In Russ.)
8. Filippenkov I.B., Shpetko Y.Y., Stavchansky V.V. et al. ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke. Biomedicines. 2024;12:2830.
9. Mozgovoy I.V., Shpetko Y.Y., Denisova A.E. et al. Differential Expression of Circular RNAs in the Frontal Cortex of the Rat Brain in Ischemia–Reperfusion. Biochemistry Moscow. 2025; 90, 568–581.
10. Mozgovoy I.V., Tsareva E.V., Denisova A.E. et al. Differential Expression of Circular RNAs in Rat Brain Regions with Various Degrees of Damage After Ischemia-Reperfusion. IJMS. 2025; 26:41226594.
11. Filippenkov I.B., Sudarkina O.Yu., Limborska S.A., Dergunova L.V. Multi-Step Splicing of Sphingomyelin Synthase Linear and Circular RNAs. Gene. 2018;654:14-22.
12. Filippenkov IB, Sudarkina OYu, Limborska SA, Dergunova LV. Circular RNA of the Human Sphingomyelin Synthase 1 Gene: Multiple Splice Variants, Evolutionary Conservatism and Expression in Different Tissues. RNA Biol. 2015;12:1030-1042.
13. Brückner G., Morawski M., Arendt T. Aggrecan-Based Extracellular Matrix Is an Integral Part of the Human Basal Ganglia Circuit. Neuroscience. 2008;151:489-504.
14. Morawski M., Brückner G., Arendt T., Matthews R.T. Aggrecan: Beyond Cartilage and into the Brain. Int J Biochem Cell Biol. 2012;44:690-693.
15. Galvan L., Francelle L., Gaillard M.C. et al. The Striatal Kinase DCLK3 Produces Neuroprotection against Mutant Huntingtin. Brain. 2018;141:1434-1454.
16. De Longprez L., Gaillard M.C., Decraene C. et al. Loss of the Neuronal Kinase DCLK3 Leads to Anxiety-like Behaviour and Memory Deficits. Brain. 2025;148:2453-2468.
17. Chen C., Chu S.F., Ai Q.D. et al. CKLF1/CCR5 Axis Is Involved in Neutrophils Migration of Rats with Transient Cerebral Ischemia. Int Immunopharmacol. 2020;85:106577.
18. Seng S., Avraham H.K., Jiang S. et al. KLHL1/MRP2 Mediates Neurite Outgrowth in a Glycogen Synthase Kinase 3beta-Dependent Manner. Mol Cell Biol. 2006;26:8371-8384.
Review
For citations:
Filippenkov I.B., Mozgovoy I.V., Sudarkina O.Y., Dergunova L.V., Andreeva L.A., Myasoedov N.F., Limborska S.A. The potential role of non-coding RNAs in the response of the transcriptome to the action of the peptide drug Semax in cerebral ischemia in rats. Medical Genetics. 2026;25(3):53-58. (In Russ.) https://doi.org/10.25557/2073-7998.2026.03.53-58
JATS XML






















